Select country change
Shopping cart (0 , 0,00 ) Menu Search

Scientific References

BioVendor collects scientific publications where the use of our immunoassays, recombinant proteins, and monoclonal and polyclonal antibodies is cited.

Filter references:
  • References to Universal Buffer

    • Emoto K, Yamashita S, Okada Y. Mechanisms of heat-induced antigen retrieval:does pH or ionic strength of the solution play a role for refolding antigens? JHistochem Cytochem. 2005 Nov;53(11):1311-21. Epub 2005 Jul 11. PubMed PMID:16009962. See more on PubMed
    • Fowler CB, Evers DL, O'Leary TJ, Mason JT. Antigen retrieval causes proteinunfolding: evidence for a linear epitope model of recovered immunoreactivity. JHistochem Cytochem. 2011 Apr;59(4):366-81. doi: 10.1369/0022155411400866. PubMed PMID: 21411808; PubMed Central PMCID: PMC3201144. See more on PubMed
    • Leong TY, Leong AS. How does antigen retrieval work? Adv Anat Pathol. 2007Mar;14(2):129-31. Review. PubMed PMID: 17471119. See more on PubMed
    • Namimatsu S, Ghazizadeh M, Sugisaki Y. Reversing the effects of formalinfixation with citraconic anhydride and heat: a universal antigen retrievalmethod. J Histochem Cytochem. 2005 Jan;53(1):3-11. PubMed PMID: 15637333. See more on PubMed
    • Siomin YA, Simonov VV, Poverenny AM. The reaction of formaldehyde withdeoxynucleotides and DNA in the presence of amino acids and lysine-rich histone. Biochim Biophys Acta. 1973 Nov 26;331(1):27-32. PubMed PMID: 4543402. See more on PubMed
    • Syrbu SI, Cohen MB. An enhanced antigen-retrieval protocol forimmunohistochemical staining of formalin-fixed, paraffin-embedded tissues.Methods Mol Biol. 2011;717:101-10. doi: 10.1007/978-1-61779-024-9_6. PubMed PMID:21370027. See more on PubMed
  • References to Urine CartiLaps® ELISA (CTX-II)

    • Henrotin Y, Bannuru R, Malaise M, Ea HK, Confavreux C, Bentin J,Urbin-Choffray D, Conrozier T, Brasseur JP, Thomas P, Hick AC, Marinello A,Giordan N, Richette P. Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study. BMCMusculoskelet Disord. 2019 Jun 18;20(1):293. doi: 10.1186/s12891-019-2667-0.PubMed PMID: 31215422; PubMed Central PMCID: PMC6580647. See more on PubMed
  • References to Urine Pre-Clinical CartiLaps® ELISA (CTX-II)

    • Henrotin Y, Bannuru R, Malaise M, Ea HK, Confavreux C, Bentin J,Urbin-Choffray D, Conrozier T, Brasseur JP, Thomas P, Hick AC, Marinello A,Giordan N, Richette P. Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study. BMCMusculoskelet Disord. 2019 Jun 18;20(1):293. doi: 10.1186/s12891-019-2667-0.PubMed PMID: 31215422; PubMed Central PMCID: PMC6580647. See more on PubMed
  • References to Urocortin 2 Mouse ELISA

    • Bale TL, Hoshijima M, Gu Y, Dalton N, Anderson KR, Lee KF, Rivier J, Chien KR,Vale WW, Peterson KL. The cardiovascular physiologic actions of urocortin II:acute effects in murine heart failure. Proc Natl Acad Sci U S A. 2004 Mar9;101(10):3697-702. Epub 2004 Feb 27. PubMed PMID: 14990799; PubMed CentralPMCID: PMC373525. See more on PubMed
    • Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjøs OD,Latchman DS, Lee KF, Vale W. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotectiverole for corticotropin releasing factor receptor type 2 in the murine heart.Endocrinology. 2004 Jan;145(1):24-35; discussion 21-3. Epub 2003 Sep 11. PubMedPMID: 12970163. See more on PubMed
    • Hinkle RT, Donnelly E, Cody DB, Bauer MB, Isfort RJ. Urocortin II treatmentreduces skeletal muscle mass and function loss during atrophy and increasesnonatrophying skeletal muscle mass and function. Endocrinology. 2003Nov;144(11):4939-46. Epub 2003 Jul 31. PubMed PMID: 12960070. See more on PubMed
    • Chen A, Vaughan J, Vale WW. Glucocorticoids regulate the expression of themouse urocortin II gene: a putative connection between thecorticotropin-releasing factor receptor pathways. Mol Endocrinol. 2003Aug;17(8):1622-39. Epub 2003 May 22. PubMed PMID: 12764078. See more on PubMed
    • Chen A, Blount A, Vaughan J, Brar B, Vale W. Urocortin II gene is highlyexpressed in mouse skin and skeletal muscle tissues: localization, basalexpression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-nullmice, and regulation by glucocorticoids. Endocrinology. 2004 May;145(5):2445-57. Epub 2004 Jan 21. PubMed PMID: 14736736. See more on PubMed
    • Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE. Urocortin II: a member of thecorticotropin-releasing factor (CRF) neuropeptide family that is selectivelybound by type 2 CRF receptors. Proc Natl Acad Sci U S A. 2001 Feb27;98(5):2843-8. PubMed PMID: 11226328; PubMed Central PMCID: PMC30227. See more on PubMed
    • Tanaka Y, Makino S, Noguchi T, Tamura K, Kaneda T, Hashimoto K. Effect ofstress and adrenalectomy on urocortin II mRNA expression in the hypothalamicparaventricular nucleus of the rat. Neuroendocrinology. 2003 Jul;78(1):1-11.PubMed PMID: 12869794. See more on PubMed
  • References to Urocortin 3 Mouse/Rat ELISA

    • Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjøs OD,Latchman DS, Lee KF, Vale W. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotectiverole for corticotropin releasing factor receptor type 2 in the murine heart.Endocrinology. 2004 Jan;145(1):24-35; discussion 21-3. Epub 2003 Sep 11. PubMedPMID: 12970163. See more on PubMed
    • Fukuda T, Takahashi K, Suzuki T, Saruta M, Watanabe M, Nakata T, Sasano H.Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factorreceptors in human adrenal and its disorders. J Clin Endocrinol Metab. 2005Aug;90(8):4671-8. Epub 2005 May 24. PubMed PMID: 15914529. See more on PubMed
    • Hsu SY, Hsueh AJ. Human stresscopin and stresscopin-related peptide areselective ligands for the type 2 corticotropin-releasing hormone receptor. NatMed. 2001 May;7(5):605-11. PubMed PMID: 11329063. See more on PubMed
    • Chanalaris A, Lawrence KM, Stephanou A, Knight RD, Hsu SY, Hsueh AJ, Latchman DS. Protective effects of the urocortin homologues stresscopin (SCP) andstresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in ratneonatal cardiomyocytes. J Mol Cell Cardiol. 2003 Oct;35(10):1295-305. PubMedPMID: 14519439. See more on PubMed
    • Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW.Identification of urocortin III, an additional member of thecorticotropin-releasing factor (CRF) family with high affinity for the CRF2receptor. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7570-5. PubMed PMID:11416224; PubMed Central PMCID: PMC34709. See more on PubMed
    • Li C, Vaughan J, Sawchenko PE, Vale WW. Urocortin III-immunoreactiveprojections in rat brain: partial overlap with sites of type 2corticotrophin-releasing factor receptor expression. J Neurosci. 2002 Feb1;22(3):991-1001. PubMed PMID: 11826127. See more on PubMed
    • Li C, Chen P, Vaughan J, Blount A, Chen A, Jamieson PM, Rivier J, Smith MS,Vale W. Urocortin III is expressed in pancreatic beta-cells and stimulatesinsulin and glucagon secretion. Endocrinology. 2003 Jul;144(7):3216-24. PubMedPMID: 12810578. See more on PubMed
    • Saruta M, Takahashi K, Suzuki T, Fukuda T, Torii A, Sasano H. Urocortin3/stresscopin in human colon: possible modulators of gastrointestinal functionduring stressful conditions. Peptides. 2005 Jul;26(7):1196-206. Epub 2005 Feb 19.PubMed PMID: 15949638. See more on PubMed
    • Takahashi K, Totsune K, Murakami O, Saruta M, Nakabayashi M, Suzuki T, Sasano H, Shibahara S. Expression of urocortin III/stresscopin in human heart andkidney. J Clin Endocrinol Metab. 2004 Apr;89(4):1897-903. PubMed PMID: 15070962. See more on PubMed